In PTCH+/− p53+/− medulloblastoma allograft mouse models and primary medulloblastoma mice, PF-5274857 inhibited tumor growth and reduced GLI1, GLI2, PTCH1, and PTCH2 gene expression with no significant side effects [103]. This evidence concerns the gene TP53 and medulloblastoma.